Carnitine Shuttle and Ferroptosis in Cancer. [PDF]
Kim YA, Lee Y, Kim MS.
europepmc +1 more source
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. [PDF]
Belenichev I +7 more
europepmc +1 more source
Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complications. [PDF]
Lei Y +10 more
europepmc +1 more source
Quantitative analysis of meldonium using electrochemical methods
openaire +1 more source
The Use of Nutritional Interventions to Enhance Genomic Stability in Mice and Delay Aging. [PDF]
van Galen I +2 more
europepmc +1 more source
Dysfunction of the carnitine cycle in tumor progression. [PDF]
Wang X, Yang C, Huang C, Wang W.
europepmc +1 more source
Inhibition of systemic mammalian metabolism by carnitine mimics from the gut microbiota
Thümmler K +20 more
europepmc +1 more source
Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review. [PDF]
Malik A, Kundur SP, Sivalokanathan S.
europepmc +1 more source
Trimethylamine-<i>N</i>-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body. [PDF]
Heinrich-Sanchez Y, Vital M.
europepmc +1 more source
Urinary excretion studies of meldonium after multidose parenteral application
Meldonium is a drug exhibiting cardioprotective and anti-ischemic effects. Due to its potential performance-enhancing benefit in sports, meldonium was added to the World Anti-Doping Agency list of prohibited substances in 2016. Since then, a high number of adverse analytical findings reported on meldonium has questioned meldonium`s detection time in ...
Guro Forsdahl +2 more
exaly +6 more sources

